Claris Lifesciences has received the Abbreviated New Drug Application (ANDA) approval for Furosemide Injection in the United States of America (US). This product will be sold in 10 mg/ml formulation packed in 20mg/2ml, 40mg/4ml and 100mg/10ml single dose vials having approximately market size of $22 million.For more information ✆ - 0731-6642300 or Visit https://www.epicresearch.co/
No comments:
Post a Comment